Montelukast
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Universita di Verona
Overview
Montelukast is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Montelukast clinical trials
Explore related
Medical disclaimer. This page summarizes research about Montelukast for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.